<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Stephansen | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/brandywave8/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/brandywave8/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Stephansen.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">90d62d422fd7fabaa9b4be20ba37754b</guid>
				<title>Stephansen posted an update: Klisyri (KX01) is a dual tubulin/Src protein inhibitor that [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40229/</link>
				<pubDate>Thu, 06 Feb 2025 14:52:04 -0800</pubDate>

									<content:encoded><![CDATA[<p>Klisyri (KX01) is a dual tubulin/Src protein inhibitor that has shown potential therapeutic effects in several tumor models. However, a phase II clinical trial in patients with bone-metastatic castration-resistant prostate cancer was halted because of lack of efficacy. We previously reported that KX01 binds to the colchicine site of β-tubulin and&hellip;<span class="activity-read-more" id="activity-read-more-40229"><a href="http://www.nationalboardinstitute.com/activity/p/40229/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1e7f34ba5e20adae11970b327f4f4c5a</guid>
				<title>Stephansen posted an update: Pulmonary arterial hypertension (PAH) is a serious [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37709/</link>
				<pubDate>Mon, 03 Feb 2025 11:55:17 -0800</pubDate>

									<content:encoded><![CDATA[<p>Pulmonary arterial hypertension (PAH) is a serious complication of systemic sclerosis (SSc) with high mortality. Interventricular systolic asynchrony (IVSA) is observed in PAH patients, but the effect of IVSA and its association with long-term mortality and clinical events in SSc-associated PAH are unclear. This study aimed to investigate the&hellip;<span class="activity-read-more" id="activity-read-more-37709"><a href="http://www.nationalboardinstitute.com/activity/p/37709/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dab303f0419ca7ca3350d5856ace863f</guid>
				<title>Stephansen posted an update: With the advent of multidetector computed tomography (CT), [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35030/</link>
				<pubDate>Fri, 31 Jan 2025 12:39:20 -0800</pubDate>

									<content:encoded><![CDATA[<p>With the advent of multidetector computed tomography (CT), CT angiography (CTA) has gained widespread popularity for noninvasive imaging of the arterial vasculature. Peripheral extremity CTA can nowadays be performed rapidly with high spatial resolution and a decreased amount of both intravenous contrast and radiation exposure. In patients with&hellip;<span class="activity-read-more" id="activity-read-more-35030"><a href="http://www.nationalboardinstitute.com/activity/p/35030/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">91f9cdac2510a8f95f580b57a28139b3</guid>
				<title>Stephansen posted an update: Lab experiments were conducted to investigate the effects of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28914/</link>
				<pubDate>Tue, 28 Jan 2025 12:10:36 -0800</pubDate>

									<content:encoded><![CDATA[<p>Lab experiments were conducted to investigate the effects of calcium oxide nanoparticles (CaO NPs) dosing on granule formation, granule development, and carbon oxide sequestration. The results showed that dosing CaO NPs adversely affected granulation due to the formation of precipitates and hydrolyzates with poor settleability. However, the&hellip;<span class="activity-read-more" id="activity-read-more-28914"><a href="http://www.nationalboardinstitute.com/activity/p/28914/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f005f2ce1ee44467d75743b64f67ee93</guid>
				<title>Stephansen became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28895/</link>
				<pubDate>Tue, 28 Jan 2025 12:01:38 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>